1414 Degrees (ASX:14D) confirmed that it complies with the listing rules in response to a letter by the ASX, according to a Friday Australian bourse filing.
It was not aware of any information not disclosed to the market that would explain the recent price surge in its shares. However, it noted a May 13 filing regarding the establishment of an aerospace and defense division focusing on the drone and aerospace market.
Its shares climbed 10% in recent trading on Friday, reaching a one-year peak.
Sai Silks (Kalamandir) (NSE:KALAMANDIR, BOM:543989) has launched a new store under the "Kalamandir" format at Davanagere in Karnataka, India, on Friday, according to a same-day disclosure to the Indian stock exchanges.This is the company's 82nd store.
Bio-Thera Solutions (SHA:688177) received drug registration certificates from China's National Medical Products Administration for ustekinumab injection, according to a Friday disclosure on the Shanghai bourse.The certificates include ustekinumab injection and ustekinumab injection in intravenous infusion form, trading as Aisali and Xisali, respectively.The Chinese drugmaker's shares slipped 1% during the afternoon trade.
South Port New Zealand (NZE:SPN) confirmed that former chief executive officer of CentrePort Derek Nind was appointed CEO, effective July 27, according to a Friday New Zealand bourse filing.South Port's current CEO, Nigel Gear, will complete his term as chief executive at the end of May. Nind stepped down from the South Port board upon confirmation of his appointment.In addition, the company's chair, Philip Cory-Wright, plans to retire from the board at the annual shareholders' meeting in October, and the board confirmed that Nicola Greer will assume the role of chair upon Cory-Wright's retirement.